Johnson & JohnsonvsWave Life Sciences

JNJ and WVE stock compared: price, dividend, valuation and results, from SEC filings.

WVE

Wave Life Sciences, Inc.

$2.73

Value $524M

-1.99%
WVE's page

Johnson & Johnson (JNJ) has a market value of $644B and Wave Life Sciences (WVE) $524M. Over the last year, with dividends, JNJ moved +36.6% and WVE -61.9%. Dividend yield: JNJ 1.98%, WVE none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$644B

    WVE$524M

    JNJ is 1,228 times WVE

  • Revenue, 12 months

    JNJ$99.3B

    WVE$71M

    JNJ is 1,401 times WVE

  • Net income, 12 months

    JNJ$16.1B

    WVE-$211M

  • Operating margin

    JNJ–

    WVE-320.9%

  • ROIC

    JNJ12.4%

    WVE-44.7%

    57.1 points apart

  • P/E

    JNJ40.0

    WVE–

  • Dividend yield

    JNJ2.0%

    WVE0.0%

    2.0 points apart

  • 5-year return

    JNJ+89.1%

    WVE-36.7%

    125.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+89.1%

WVE-36.7%

20040020222023202420252026
Returns by period
PeriodJNJWith dividendsWVEWith dividends
1 year since November 18, 2025+36.6%Price +33.6%-61.9%Price -61.9%
3 years since November 17, 2023+94.2%+24.8% a yearPrice +78.4%-50.8%-21.1% a yearPrice -50.8%
5 years since November 18, 2021+89.1%+13.6% a yearPrice +64.5%-36.7%-8.7% a yearPrice -36.7%
10 years since November 21, 2016+202.7%+11.7% a yearPrice +132.3%-92.9%-23.2% a yearPrice -92.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonWVEWave Life Sciences

Valuation

JNJWVE
Valuation
Price$267.06$2.73
Market value$644B$524M
Enterprise value (EV)$671B$93M
P/E40.0–
P/E, 5-year median21.9–
P/B7.91.3
EV/EBIT37.8–
Free cash flow yield3.2%–

Results and growth

JNJWVE
Results and growth
Revenue, 12 months$99.3B$71M
Net income, 12 months$16.1B-$211M
Free cash flow, 12 months$20.6B-$208M
Earnings per share, 12 months$6.59-$1.06
Revenue growth, year on year6.1%-60.6%
Revenue growth a year, past+2.7%over 5 years+16.3%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJWVE
Margins and returns on capital
Gross margin67.6%–
Operating margin–-320.9%
Net margin16.2%-296.9%
ROIC12.4%-44.7%
ROE19.7%-52.4%

Balance sheet

JNJWVE
Balance sheet
Cash$17.2B$431M
Total debt$44.7B$43M
Net debt / EBITDA1.1–
Interest cover18.0×–

Dividends and buybacks

JNJWVE
Dividends and buybacks
Dividend yield2.0%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or WVE

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Wave Life Sciences?

By market value, Johnson & Johnson ($644B) is about 1,227.9 times Wave Life Sciences ($524M), at today's prices.

How did JNJ and WVE stock do over the last 10 years?

Since November 21, 2016, JNJ's price moved +132.3% and WVE's -92.9%. With dividends: JNJ +202.7% (+11.7% a year), WVE -92.9% (-23.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or WVE?

The dividend yield at today's price is 1.98% for Johnson & Johnson and none for Wave Life Sciences. Over the last twelve months they paid $5.28 and – per share.

Which has the higher profit margins, Johnson & Johnson or Wave Life Sciences?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and -296.9% for Wave Life Sciences, and the operating margin – and -320.9%. Revenue was $99.3B and $71M.

Which is the better investment, Johnson & Johnson or Wave Life Sciences?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.